» Articles » PMID: 28161582

Opinion Article on Lipidomics: Inherent Challenges of Lipidomic Analysis of Sphingolipids

Overview
Publisher Elsevier
Date 2017 Feb 6
PMID 28161582
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A challenge for sphingolipidomic analysis is the vast number of subspecies, including a large number of isomers-a complication that was even appreciated by the original discoverer of sphingolipids J. L. W. Thudichum (The Chemistry of the Brain, p. x, 1884): "In the course of my researches many unforeseen complications arose, prominent amongst which were those caused by the occurrence of chemical principles having the same atomic or elementary composition, but differing in other chemical, or in physical properties, varieties producing the phenomenon which in chemistry is termed isomerism." Therefore, it is essential to choose the appropriate method(s) for the goal of the analysis, to know the assumptions and limitations of method(s) used, and to temper interpretation of the data accordingly. This article is part of a Special Issue entitled: BBALIP_Lipidomics Opinion Articles edited by Sepp Kohlwein.

Citing Articles

Don't Be Surprised When These Surprise You: Some Infrequently Studied Sphingoid Bases, Metabolites, and Factors That Should Be Kept in Mind During Sphingolipidomic Studies.

Merrill Jr A Int J Mol Sci. 2025; 26(2).

PMID: 39859363 PMC: 11765627. DOI: 10.3390/ijms26020650.


Unraveling the complexity of glycosphingolipidome: the key role of mass spectrometry in the structural analysis of glycosphingolipids.

Horejsi K, Holcapek M Anal Bioanal Chem. 2024; 416(25):5403-5421.

PMID: 39138658 PMC: 11427620. DOI: 10.1007/s00216-024-05475-7.


ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipids.

Allwright M, Guennewig B, Hoffmann A, Rohleder C, Jieu B, Chung L Sci Rep. 2024; 14(1):4375.

PMID: 38388524 PMC: 10883992. DOI: 10.1038/s41598-024-53860-0.


Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids.

DeVeaux S, Ogle M, Vyshnya S, Chiappa N, Leitmann B, Rudy R Cytotherapy. 2022; 24(6):608-618.

PMID: 35190267 PMC: 10725732. DOI: 10.1016/j.jcyt.2021.12.009.


Identification of circulating sphingosine kinase-related metabolites for prediction of type 2 diabetes.

Chen Q, Wang W, Xia M, Lu Y, Bian H, Yu C J Transl Med. 2021; 19(1):393.

PMID: 34530846 PMC: 8447705. DOI: 10.1186/s12967-021-03066-z.


References
1.
Liebisch G, Vizcaino J, Kofeler H, Trotzmuller M, Griffiths W, Schmitz G . Shorthand notation for lipid structures derived from mass spectrometry. J Lipid Res. 2013; 54(6):1523-1530. PMC: 3646453. DOI: 10.1194/jlr.M033506. View

2.
Jimenez-Rojo N, Sot J, Busto J, Shaw W, Duan J, Merrill Jr A . Biophysical properties of novel 1-deoxy-(dihydro)ceramides occurring in mammalian cells. Biophys J. 2014; 107(12):2850-2859. PMC: 4269796. DOI: 10.1016/j.bpj.2014.10.010. View

3.
Sullards M, Liu Y, Chen Y, Merrill Jr A . Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS). Biochim Biophys Acta. 2011; 1811(11):838-53. PMC: 3205276. DOI: 10.1016/j.bbalip.2011.06.027. View

4.
Russo S, Tidhar R, Futerman A, Cowart L . Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties. J Biol Chem. 2013; 288(19):13397-409. PMC: 3650378. DOI: 10.1074/jbc.M112.428185. View

5.
Kliman M, May J, McLean J . Lipid analysis and lipidomics by structurally selective ion mobility-mass spectrometry. Biochim Biophys Acta. 2011; 1811(11):935-45. PMC: 3326421. DOI: 10.1016/j.bbalip.2011.05.016. View